Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 2.59% | 153.58 | 0.0% | $1235.68m | |
| AMGN | Amgen, Inc. | 0.00% | 249.95 | 1.3% | $706.86m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | 0.00% | 8.00 | 0.7% | $559.23m | |
| NVAX | Novavax, Inc. | -1.11% | 192.50 | 80.0% | $533.69m | |
| ILMN | Illumina, Inc. | 0.00% | 403.15 | 3.5% | $527.32m | |
| GILD | Gilead Sciences, Inc. | -0.45% | 64.60 | 1.0% | $470.31m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.27% | 478.32 | 2.7% | $432.27m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 0.25% | 216.48 | 1.9% | $372.99m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.00% | 153.73 | 2.0% | $315.33m | |
| BIIB | Biogen, Inc. | 0.00% | 266.19 | 1.7% | $292.97m | |
| BNTX | BioNTech SE | 0.28% | 130.00 | 0.0% | $219.41m | |
| EXAS | EXACT Sciences Corp. | 1.48% | 129.89 | 18.4% | $197.74m | |
| NBIX | Neurocrine Biosciences, Inc. | 0.00% | 92.97 | 4.9% | $172.50m | |
| CRSP | CRISPR Therapeutics AG | 0.47% | 121.45 | 0.6% | $170.15m | |
| TXG | 10X Genomics, Inc. | 0.00% | 197.36 | 0.0% | $149.02m |
Company Profile
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically-humanized mice to produce optimized fully-human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.